The Swiss Group for Clinical Cancer Research (SAKK) is delighted to announce the appointment of Prof. Dr. med. Alexandre Theocharides as the new president of the Leukemia Project Group. This decision marks significant progress in leukemia research and underscores SAKK’s unwavering commitment to innovation in oncology.

Prof. Dr. med. Alexandre Theocharides, who serves as the Head of Clinical Studies at CCCZ and Senior Attending Physician at the Department of Medical Oncology and Hematology at the University Hospital Zurich (USZ), brings extensive expertise that will enrich the work of the SAKK cancer research.

We warmly congratulate him on his new position and look forward to seeing the positive impact of his dedication within the project group.

For more information about the project groups and ongoing research activities, please visit our website.